CTRI/2024/05/068054
Not yet recruiting
未知
To study the utility of Estrogen Receptor and Progesterone Receptor expression as an immunohistochemical predictive markers for tumour behaviour in comparison to histopathological parameters and Tumour, Lymph Node and Metastatic staging in colorectal carcinoma - Nil
Datta Meghe Institute of Higher Education & Research (DMIHER)0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Datta Meghe Institute of Higher Education & Research (DMIHER)
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Previously diagnosed as Colorectal carcinoma on histopathology
- •2\) All colorectal carcinoma cases that are operated
- •3\) Colorectal carcinoma cases that are primary cases and have not received any previous treatment
- •4\) All patients diagnosed with colorectal carcinoma occurring spontaneously.
Exclusion Criteria
- •1\) All non\-cancerous lesions found in the colon and rectum
- •2\) All previously treated cases of colorectal carcinoma
- •3\) All patients with colorectal carcinoma experiencing cancer recurrence
- •4\) Patients lacking histological confirmation of colorectal carcinoma.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Benefit of giving estrogen in IVF cycles.Health Condition 1: null- Infertile patients undergoing IVFCTRI/2017/10/010083Maulana Azad Medical College and Lok Nayak Hospital150
Completed
Not Applicable
Clinical Trial of a Selective Estrogen Receptor Modulator (raloxifene) in Schizophreniacognitive deficits in patients with schizophreniapsychotic symptoms in patients with schizophreniaMental Health - SchizophreniaACTRN12608000461392niversity of New South Wales80
Active, not recruiting
Phase 1
Evaluating the effect of a drug that at full-term preganacy, softens the neck of the womb ready for deliveryEUCTR2019-002032-84-CZDisphar International B.V150
Completed
Not Applicable
Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary TumorBreast CancerNCT05797987Fudan University52
Completed
Not Applicable
Efficacy of selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment for menopausal women with chronic hepatitis C womeMenopausal women with chronic hepatitis CJPRN-UMIN000005815Department of General Internal Medicine, Kyushu University Hospital120